Brief: Neurosense And Genetika+ Initiate Precision Medicine Collaboration

Neurosense Therapeutics

22/04/2024 13:36

April 22 (Reuters) - Neurosense Therapeutics Ltd
 NRSN.O :
    * NEUROSENSE AND GENETIKA+ INITIATE PRECISION MEDICINE
COLLABORATION BEGINNING WITH ONGOING PHASE 2 CLINICAL TRIAL IN
ALZHEIMER'S DISEASE
    * NEUROSENSE THERAPEUTICS: STUDY EXPECTED TO REVEAL SAFETY
OF
PRIMEC IN AD, AND SHED LIGHT ON EFFICACY, BIOLOGICAL ACTIVITY OF
COMBINATION THERAPY
    * NEUROSENSE THERAPEUTICS: STUDY EXPECTED TO REVEAL SAFETY
OF
PRIMEC IN AD, AND SHED LIGHT ON EFFICACY, BIOLOGICAL ACTIVITY OF
COMBINATION THERAPY

Source text for Eikon:  ID:nPn9jJLC7a 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))